Ligand Pharmaceuticals
LGND
#4130
Rank
NZ$3.42 B
Marketcap
$177.87
Share price
-0.67%
Change (1 day)
51.09%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.53

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.64. In 2022 the company made an earnings per share (EPS) of -$3.33 a decrease over its 2021 EPS that were of $5.82.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.53-176.12%
2022-$3.33-157.23%
2021$5.82-2571.43%
2020-$0.24-100.46%
2019$51.48353.48%
2018$11.351025%
2017$1.01-700%
2016-$0.17-100.87%
2015$19.441859.32%
2014$0.995.36%
2013$0.948.0704505322479E+18%
2012$0.0000000000-100%
2011$0.82-194.23%
2010-$0.87548.38%
2009-$0.13-98.7%
2008-$10.39-136.52%
2007$28.46-787.8%
2006-$4.14-14.58%
2005-$4.84-21.31%
2004-$6.16-55.15%
2003-$13.7281.33%
2002-$7.572.74%
2001-$7.37-45.93%
2000-$13.62-14.56%
1999-$15.94-45.52%
1998-$29.26-3.97%
1997-$30.47132.31%
1996-$13.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$23.80 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.61-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.89 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.06 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.13 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.13 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.68 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.61 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.69 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA